Clinical Trials Logo

Tenofovir Alafenamide Fumarate clinical trials

View clinical trials related to Tenofovir Alafenamide Fumarate.

Filter by:
  • None
  • Page 1

NCT ID: NCT05853718 Recruiting - Chronic Hepatitis b Clinical Trials

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

Start date: May 6, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics, efficacy and safety of TAF in HBV-infected pregnant women.

NCT ID: NCT04850950 Not yet recruiting - Chronic Hepatitis B Clinical Trials

Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B

TAF-PPT
Start date: April 26, 2021
Phase: Phase 4
Study type: Interventional

To investigate the safety and efficacy of tenofovir alafenamide (orally 25 mg per day) treated in inactive chronic hepatitis B virus (HBV)-infected pregnant women with high viral load from the late pregnancy until the delivery date or postpartum 1 month.